APA (7th ed.) Citation

Yun, W., Kim, D., Han, Y., Kwon, W., Lee, S., Jang, J., & Park, D. Multiomic quantification of the KRAS mutation dosage improves the preoperative prediction of survival and recurrence in patients with pancreatic ductal adenocarcinoma. Nature Publishing Group.

Chicago Style (17th ed.) Citation

Yun, Won-Gun, Daeun Kim, Youngmin Han, Wooil Kwon, Seong-Geun Lee, Jin-Young Jang, and Daechan Park. Multiomic Quantification of the KRAS Mutation Dosage Improves the Preoperative Prediction of Survival and Recurrence in Patients with Pancreatic Ductal Adenocarcinoma. Nature Publishing Group.

MLA (9th ed.) Citation

Yun, Won-Gun, et al. Multiomic Quantification of the KRAS Mutation Dosage Improves the Preoperative Prediction of Survival and Recurrence in Patients with Pancreatic Ductal Adenocarcinoma. Nature Publishing Group.